Prof. Bassermann is an acknowledged expert and an emerging leader in the field of hematological malignancies such as multiple myeloma and lymphoma. His research is aimed at elucidating principles of ubiquitin-dependent signaling in fundamental and cancer relevant cellular functions such as cell cycle control, DNA repair, transcription, protein synthesis, cell differentiation and apoptosis. The group works towards the identification of new therapeutic targets and guides the development of rationally designed targeted therapies and biomarkers.

As an example, his group has recently published work on the deubiquitinase Usp9x and its involvement in mediating resistance to anti-tubulin chemotherapeutics in aggressive B-cell lymphoma in EMBO Mol Med.

More information about Prof. Bassermann´s research can be found under:

www.med3.med.tum.de/forschung/Grundlagenforschung/Zellzyklusregulation/index.html

www.bassermann-lab.med3.med.tum.de/index.php

www.mri.tum.de/node/3539

and a few recent key publications:

www.ncbi.nlm.nih.gov/pubmed/27317434
www.ncbi.nlm.nih.gov/pubmed/27294876
www.ncbi.nlm.nih.gov/pubmed/25419709
www.ncbi.nlm.nih.gov/pubmed/23263282

If you wish to meet with Prof. Bassermann in person please contact Dr. Inga Melzer ( inmelzer@uni-mainz.de) until the 17.01.2017. The formal lecture will be followed by a wine and cheese reception.